The use of propofol for induction of anaesthesia in dogs premeditated with acepromazine, butorphanol and acepromazine-butorphanol

New Zealand Veterinary Journal

Volumn 45, Issue 4, 1997, Pages 129-134

  Bufalari, A ^a   Miller, S M ^a   Short, C E ^a   Giannoni, G ^a  

^a Animal Health Diagnostic Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 24644501862     PISSN: 00480169     EISSN: 11760710     Source Type: Journal    
DOI: 10.1080/00480169.1997.36012     Document Type: Article

References (35)

1. Morgan DWJ, Legge K. Clinical evaluation of propofol as an intravenous anesthetic agent in cats and dogs. Veterinary Record 124, 31-3, 1989.
2. Weaver BMQ, Raptopoulos D. Induction of anesthesia in dogs and cat with propofol. Veterinary Record 126, 617-20, 1990.
3. Geel JK. The effect of premedication on the induction dose of propofol in dogs and cats. Journal of the South African Veterinary Association 62,118-23,1991.
4. Watney GCG, Pablo LS. Median effective dosage of propofol for induction of anesthesia in dogs. American Journal of Veterinary Research 53, 2320-2, 1992.
5. Popio KA, Jackson DH, Ross AM, Shreiner BF, Yu PN. Hemodynamic and respiratory effects of morphine and butorphanol. Clinical Pharmacology and Therapeutics 23, 281-7, 1978.
6. Vandam LD. Butorphanol. New England Journal of Medicine 302,3814, 1980.
7. Duthie DJR, Nimmo WS. Adverse effects of opioid analgesic drugs. British Journal of Anaesthesia 59, 61-77, 1987.
8. Orsini JA. Butorphanol tartrate: Pharmacology and clinical indications. Compendium on Continuing Education 10, 849-54, 1988.
9. Trim CM. Cardiopulmonary effects of butorphanol tartrate in dogs. American Journal of Veterinary Research 44, 329-31, 1983.
10. Dyson DH. Update on butorphanol tartrate: Use in small animals. Canadian Veterinary Journal 31, 120-1, 1990.
11. Schurig JE, Cavanagh RL, Buyniski JP. Effect of butorphanol and morphine on pulmonary mechanics, arterial blood pressure and venous plasma histamine in the anesthetized dog. Archives Internationales de Pharmacodynamie and de Therapie 233, 296-304, 1978.
12. Greene SA, Hartsfield SM, Tyner CL. Cardiovascular effects of butorphanol in halothane-anesthetized dogs. American Journal of Veterinary Research 51, 1276-9, 1990.
13. Verstegen J, Petcho A. Medetomidine-butorphanol-midazolam for anaesthesia in dogs and its reversal by atipamezole. Veterinary Research 3,353-7,1993.
14. Short CE, Tyner CI, Matthews N, McMurphy R. Preanesthetic and postoperative pain relief in dogs: Comparing analgesics. Veterinary Medicine 82, 744-51, 1987.
15. Dyson DH, Atilola M. A clinical comparison of oxymorphone-acepromazine and butorphanol-acepromazine sedation in dogs. Veterinary Surgery 21, 418-21, 1992.
16. Robertson SA, Johnston S, Beemsterboer J. Cardiopulmonary, anesthetic and postanesthetic effects of intravenous infusion of propofol in greyhounds and non-greyhounds. American Journal of Veterinary Research 53, 1027-32, 1992.
17. Popovic NA, Mullane JF, Yhap EO. Effects of acetylpromazine maleate on certain cardiorespiratory responses in dogs. American Journal of Veterinary Research 33, 1819-24, 1972.
18. Sebel PS, Lowdon JD. Propofol: A new intravenous anesthetic. Anesthesiology 71, 260-77, 1989.
19. Altman DG. Comparing groups-continuous data. In: Altman DG (ed). Practical Statistics for Medical Research. 1 st Edtn. Chapter 9. Pp 179-228. Chapman and Hall, London, 1991.
20. Fisher DM. Statistics in anesthesia. In: Miller RD (ed). Anesthesia. 6th Edtn. Pp 755-88. Churchill and Livingstone, New York, 1994.
21. Short CE, Greenwald W, Bendick F. Oxygen, carbon dioxide, and pH responses in arterial blood of dogs given analgesic, neuroleptanalgesic, and ataractic agents. Journal of the American Veterinary Medical Association 156, 1406-10, 1970.
22. Glen JB, Hunter SC. Pharmacology of an emulsion formulation of ICI 35868. British Journal of Anaesthesia 56, 617-25, 1984.
23. Langley MS, Rennie CH. Propofol: A review of its pharmacodynamic and pharmacokinetic properties and use as intravenous anesthetic. Drugs 35, 334-72, 1988.
24. Pircio AW, Gylys JA, Cavanagh RL, Buyniski JP, Bierwagen ME. The pharmacology of butorphanol, a 3,14-dihydroxymorphinan narcotic antagonist analgesic. Archives Internationales de Pharmacodynamie and de Therapie 220, 231-57, 1976.
25. 2 anesthetized healthy dogs. American Journal of Veterinary Research 50, 1340-2, 1989.
26. Heel RC, Brogden RN, Speight TM, Avery GS. Butorphanol: A review of its pharmacological properties and therapeutic efficacy. Drugs 16, 473-505, 1978.
27. McCrackin MA, Harvey RC, Sackman JE, McLean RA, Paddleford RR. Butorphanol tartrate for partial reversal of oxymorphone-induced postoperative respiratory depression in the dog. Veterinary Surgery 23, 67-74, 1994.
28. Watkins SB, Hall LW, Clarke KW. Propofol as an intravenous anesthetic agent in dogs. Veterinary Record 120, 326-9, 1987.
29. Roily G, Versichelen L, Huyghe L, Mungroop H. Effect of speed of injection on induction of anesthesia using propofol. British Journal of Anaesthesia 57, 743-6, 1985.
30. Saint Maurice C. Propofol in pediatric anesthesia. Canadian Anesthesiology 39, 411-20, 1991.
31. Gillies GWA, Lees NW. The effects of speed of injection on induction with propofol. Anaesthesia 44, 386-88, 1989.
32. Scott RP, Saunders DA, Norman J. Propofol: Clinical strategies for preventing the pain of injection. Anaesthesia 43, 492-4, 1988.
33. Smith JA, Gaynor JS, Bednarski RM, Muir WW. Adverse effects of administration of propofol with various preanesthetic regimens in dogs. Journal of the American Veterinary Medical Association 202, 1111-15, 1993.
34. Huang CL, Wang YP, Cheng YJ, Susetio L, Liu CC. The effect of carrier intravenous fluid speed on the injection pain of propofol. Anesthesia and Analgesia 81, 1087-8, 1995.
35. Whitesell R, Asiddao C, Gollman D, Jablovski I. Relationship between arterial and peak expired carbon dioxide pressure during anesthesia and factors influencing the difference. Anesthesia and Analgesia 31, 5549, 1981.